Article
The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell Lymphoma
2025-11-12
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is the most common and clinically aggressive subtype of non-Hodgkin lymphoma (NHL). Although novel therapeutic agents, in-cluding rituximab and polatuzumab vedotin, have improved outcomes, almost one-third of patients ultimately develop relapsed or refractory disease. MicroRNAs (miRNAs), a class of endogenous single-stranded RNAs approximately 22 nucleotides in length, play a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 655306a2-341f-5522-b4b5-5b052e731bdc
- DOI
- 10.20944/preprints202511.0744.v1
